Efficacy of cancer chemotherapy in relation to synchronization of cortisol rhythm, immune status and psychospiritual profilein metastatic non-small cell lung cancer

In Vivo

Volumn 22, Issue 2, 2008, Pages 257-262

  Lissoni, Paolo ^a   Messina, G ^a   Balestra, A ^a   Colciago, M ^b   Brivio, F ^a   Fumagalli, L ^a   Fumagalli, G ^a   Parolini, D ^a  

^a SAN GERARDO HOSPITAL   (Italy)

^b Hospital of Carate   (Italy)

Author keywords

Chemotherapy; Cortisol rhythm; Lymphocytopenia; Psychoncology

Indexed keywords

CISPLATIN; GEMCITABINE; HYDROCORTISONE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CIRCADIAN RHYTHM; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; ENDOCRINE FUNCTION; FEMALE; HORMONE ACTION; HUMAN; IMMUNE RESPONSE; LOW DRUG DOSE; LUNG NON SMALL CELL CANCER; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; MULTIPLE CYCLE TREATMENT; NEUROENDOCRINE SYSTEM; NUCLEAR MAGNETIC RESONANCE; PERSONALITY TEST; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PSYCHOLOGICAL ASPECT; RELIGION; SCORING SYSTEM; SEXUALITY; TREATMENT RESPONSE; TUMOR REGRESSION;

EID: 42149169759     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Riesco A: Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils. Cancer 25: 135-140, 1970.
2. Bruder S, Muul L and Waidmann TA: Suppressor cells in neoplastic disease. J Natl Cancer Inst 61: 5-11, 1978.
3. Grimm EA, Mazumder A, Zhang HZ and Rosenberg SA: Lymphokine-activated killer cell phenomenon. J Exp Med 155: 1823-1841, 1982.
4. van der Pompe G, Antoni MH and Heijnen CJ: Elevated basal cortisol levels and attenuated ACTH and cortisol response to a behavioral challenge in women with metastatic breast cancer. Psychoneuroendocrinology 21: 361-374, 1996.
5. Mormont MC and Levi F: Circadian system alterations during cancer processes: a review. Int J Cancer 70: 241-247, 1997.
6. Atzpodien J and Kirchner H: Cancer, cytokines and cytotoxic cells. Klin Wochenschr 68: 1-11, 1990 (in English).
7. Lissoni P, Brivio F, Fumagalli L, Di Fede G and Brera G: Enhancement of the efficacy of chemotherapy with oxaliplatin plus 5-fluorouracil by pre-treatment with IL-2 subcutaneous immunotherapy in metastatic colorectal cancer patients with lymphocytopenia prior to therapy. In Vivo 19: 1077-1080, 2005.
8. Lissoni P, Barni S, Rovelli F and Tancini G: Lower survival in metastatic cancer patients with reduced interleukin-2 blood concentrations. Oncology 48: 125-127, 1991.
9. Sephton SE, Sapolsky RM, Kraemer HC and Spiegel D: Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 92: 994-1000, 2000.
10. Claman HN: Corticosteroids and the immune system. Adv Exp Med Biol 245: 203-210, 1998.
11. Rubinow DR: Brain, behaviour and immunity: an interactive system. I Natl Cancer Inst Monogr 10: 79-82, 1990.
12. Lissoni P, Brivio F, Fumagalli L, Messina G, Secreto G, Romelli B, Fumagalli G, Rovelli F, Colciago M and Brera G: Immune and Endocrine Mechanism of Advanced Cancer-related Hypercortisolemia. In Vivo 21: 647-650, 2007.
13. Rorschach H: Psychodiagnostics. Huber HA (ed.). Bern, Verlag, 1921.
14. Messina G, Lissoni P and Bartolacelli E: A clinical test fort he spirituality in healthy subjects. It J Psychiatry Behav Sci, in press (in English).
15. Messina G, Bartolacelli E, Lissoni P, Carta I, Brivio F and Gardani G: Psychological investigation in cancer patients: response to the Rorschach's test in relation to the histotype of tumors. It J Psychiatry Behav Sci 15: 59-63, 2005 (in English).
16. Ursin H: The psychology in psychoneuroendocrinology. Psychoneuroendocrinology 23: 555-570, 1998.
17. Ehrke MJ, Mohich E, Berd D and Mastangelo MJ: Effects of anticancer drugs on the immune system in humans. Semin Oncol 16: 230-241, 1989.
18. Jankovic BD: Neuroimmunomodulation. Ann NY Acad Sci 741: 3-38, 1994.